Inventor · disambiguated record
Takuya Ishii
Also filed as: ISHII TAKUYA
4 granted patents·8 pending applications·3 citations·filing 2007–2022
59Inventor score
Top patents by PatentIndex Score
12 records- 0169US9351949B2Prophylactic/therapeutic agent for influenza virus infectionSBI PHARMACEUTICALS CO LTD·Filed 2013·Granted May 31, 2016·2 cites·8 claims
- 0269US2022370395A1Enhancer of photodynamic effect in ala-pdt or ala-pddSBI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0367US9345904B2Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acidTANAKA TOHRU·Filed 2012·Granted May 24, 2016·1 cites·3 claims
- 0464US2009011018A1Sustained release formulation for tacrolimusASTELLAS PHARMA INC·Filed 2007·Application pending·0 cites
- 0564US2008181947A1Controlled release dosage form of tacrolimusASTELLAS PHARMA INC·Filed 2007·Application pending·0 cites
- 0658US2020030275A1Enhancer of photodynamic effect in ala-pdt or ala-pddSBI PHARMACEUTICALS CO LTD·Filed 2018·Application pending·0 cites
- 0754US2024189269A1Pharmaceutical composition for suppressing tmprss2 expressionTOKYO INST TECH·Filed 2021·Application pending·0 cites
- 0851US2011142933A1Controlled Release Dosage Form of TacrolimusASTELLAS PHARMA INC·Filed 2011·Application pending·0 cites
- 0948US9517267B2Photodynamic diagnostic agent and photobleaching inhibitorSBI PHARMACEUTICALS CO LTD·Filed 2013·Granted Dec 13, 2016·0 cites·12 claims
- 1044US2015038837A1Device for determining metastasis of cancer to sentinel lymph nodeSBI PHARMACEUTICALS CO LTD·Filed 2013·Application pending·0 cites
- 1142US2011281906A1Sustained release formulation for tacrolimusKONDO HIROMU·Filed 2011·Application pending·0 cites
- 1240US9550073B2Therapeutic agent for allergic rhinitisTANAKA TOHRU·Filed 2012·Granted Jan 24, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Takuya Ishii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →